Russia's "Sputnik V" Vaccine 92% Effective Against "Symptomatic" COVID Cases | WHAT REALLY HAPPENED

Russia's "Sputnik V" Vaccine 92% Effective Against "Symptomatic" COVID Cases

As it turns out, the Kremlin wasn't embellishing when it first said its COVID vaccine, developed by the Gamaleya Institute with financing from Russia's Sovereign Wealth Fund, was as effective as the best Western vaccines. According to the official data, Russia's Sputnik V vaccine has 91.6% efficacy rate against symptomatic coronavirus cases.

These preliminary findings are based on an analysis of data from more than 20K, mostly white, participants, 3/4ths of whom received the vaccine, while the rest received a placebo. No serious adverse health impacts were reported; most negative health effects included flu-like symptoms, pain at the injection site and weakness or lethargy,

"Sputnik V" was administered in two injections 21 days apart, just like similar counterparts in the west. In the 21 days after the first dose, there were 16 cases of COVID-19 in the 14,964 people (0.1%) in the vaccine group, and 62 cases of the disease in the 4.9K individuals (1.3%) in the placebo group.